Your new post is loading...
From
uber
John McElhenney (@jmacofearth) writes:
"The recent storm over Pfizer's Facebook Page being hacked has brought the social media and pharma discussion back into the public spotlight.
Do the pharmaceutical companies provide valuable information through channels like Facebook and Twitter, or is it merely advertising cloaked as social media conversations?
How much of what is deemed "social media" is simply repackaging of the drug maker's message and how much of it is actual discussion and dialogue?"
